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A lack of peptide binding and decreased
thermostability suggests that the CASKIN2
scaffolding protein SH3 domain may be
vestigial
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Abstract
Background: CASKIN2 is a neuronal signaling scaffolding protein comprised of multiple ankyrin repeats, two
SAM domains, and one SH3 domain. The CASKIN2 SH3 domain for an NMR structural determination because its
peptide-binding cleft appeared to deviate from the repertoire of aromatic enriched amino acids that typically
bind polyproline-rich sequences.
Results: The structure demonstrated that two non-canonical basic amino acids (K290/R319) in the binding cleft
were accommodated well in the SH3 fold. An K290Y/R319W double mutant restoring the typical aromatic amino
acids found in the binding cleft resulted in a 20 °C relative increase in the thermal stability. Considering the reduced
stability, we speculated that the CASKIN2 SH3 could be a nonfunctional remnant in this scaffolding protein.
Conclusions: While the NMR structure demonstrates that the CASKIN2 SH3 domain is folded, its cleft has suffered
two substitutions that prevent it from binding typical polyproline ligands. This observation led us to additionally
survey and describe other SH3 domains in the Protein Data Bank that may have similarly lost their ability to
promote protein-protein interactions.
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Background
A pair of neuronal scaffolding proteins, represented in
humans by CASKIN1 and CASKIN2, participate in
signaling pathways involved in axon guidance and the
creation of neuromuscular junctions. While mammals
possess two CASKIN homologs, Drosophila only pos-
sesses one form (Ckn) that differs in domain compos-
ition and C. elegans has no homolog at all leading to
the idea that the general role of CASKINs may be to
provide more complex signaling outcomes in higher
organisms by recruiting additional sets of protein part-
ners [1]. Typical for many scaffolding proteins [2, 3],
CASKIN1 and CASKIN2 are composed entirely of
protein-protein interaction domains including six ankyrin
repeats, an SH3 domain and tandem SAM domain
(Fig. 1a). The C-terminal half of the protein, spanning over
600 residues and only partially conserved, is characterized
by a proline-rich segment of unknown function [4].
CASKIN1, and CASKIN2 by homology, were named
by their ability to serve as ligands of the MAGUK pro-
tein, CASK, a prominent signaling protein linked to cal-
cium mediated signaling events, actin microfilament
assembly, and synaptic communication through the
neurexin cell surface receptor [4, 5]. Later structural
studies of CASKIN1 revealed that the CASK interaction
domain (CID), shared with X11/Mint and located in a
region between the SH3 and SAM domains, was not
present in CASKIN2. Thus, the namesake of CASKIN2
is misleading because it is unable to bind the calmodulin
kinase domain of CASK [6]. This distinction lead us to
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Fig. 1 Domain organization of CASKIN2 and structure features of its SH3 domain. a CASKIN2, unlike CASKIN1, cannot bind the CASK scaffolding
protein due to the absence of a CASK interacting domain (CID). The CASKIN sequences diverge in a proline rich (P-rich region), ultimately ending
with a conserved C-terminal sequence of unknown significance. b Sequence comparison of the CASKIN2 and CASKIN1 SH3 domains. Black dots
indicate amide resonances that could not be assigned, characteristic of intermediate (μs-ms) motions. Secondary structure of the CASKIN2 SH3
domain is shown below its sequence. Six amino acids constituting the canonical binding cleft are colored. c Cα superposition of the ensemble of
lowest energy structures submitted to the Protein Data Bank (PDB: 2KE9) d Among the six amino acids in a typical peptide binding cleft, position
1 (K290) and position 5 (R319) are non-canonical. e A survey of binding clefts from SH3 domains in the Protein Data Bank that vary from the
typical compliment of aliphatic and aromatic amino acids exemplified by Abl (PDB: 1ABO). From the survey, SH3 domains are observed to bear
substitutions at one or more of the six positions (indicated by shading)
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CASKIN1 and CASKIN2 may have diverged with re-
spect to their scaffolding functions in neurons [7].
Owing to the prominence of CASK in the develop-
ment of neurological disease [8, 9], research to date has
concentrated on CASKIN1 [10–12]. In this report, we
have concentrated on the CASKIN2 SH3 domain to
explore the question of whether functional differences
between CASKIN1 and CASKIN2 extend to the struc-
tural level. Building upon the NMR solution structure
of the CASKIN2 SH3 domain, we demonstrate that the
typical binding cleft has two hydrophobic amino acid
substitutions that do not affect the overall fold, but do
affect thermostability and the ability to interact with
peptides. These observations led us to consider that the
CASKIN2 SH3 domain was non-functional. When
hydrophobic amino acids were reintroduced, thermo-
stability increased and high affinity binding was re-
stored towards a peptide ligand of one of CASKIN2’s
most homologous family members.
Results and discussion
Domain organization and sequence similarity
The CASKIN1 and CASKIN2 SH3 domains are located
at the same position within each protein and are ap-
proximately 60 % similar (Fig. 1b). Following the SH3
domain, CASKIN1 and CASKIN2 diverge in sequence,
the notable differences being the lack of a CASK inter-
action domain (CID) in CASKIN2, as well as the length
and composition of a carboxy terminal proline-rich re-
gion. Thus, depending on the perspective, CASKIN1 and
CASKIN2 are simultaneously similar and different, and
therefore warrant some caution when making functional
assumptions about one protein in the absence of know-
ledge from the other.
Structure of the CASKIN2 SH3 domain
We began this study with a NMR solution structure de-
termination of the CASKIN2 SH3 domain to provide a
high-resolution framework for exploring how the SH3
domain may interact with ligands and react to post-
translational modifications. Backbone atom precision for
the ensemble of structures was 0.60 ± 0.14 Å, consistent
with the number of experimental observations used in
the structure calculation. Complete statistics pertaining
to the experimental observations and structural quality
are presented in Table 1. From the ensemble of the low-
est energy structures, the RT and N-Src loops presented
a high degree of disorder (Fig. 1c), presumably due to
the absence of a ligand. Experimentally, the decrease in
backbone atom precision is manifested by missing back-
bone assignments (D297, S327-D330, and R333) and
short-range NOE observations (depicted as dots above
the sequence in Fig. 1). A survey of the PDB for similar
structures revealed the SH3 domains from human
KIAA17833 and yeast NBP2 (both from structural prote-
omics studies) along with the well characterized SH3
domain from STAM2 [13] (Table 2).
The CASKIN2 SH3 domain peptide binding cleft
A typical SH3 domain presents a binding cleft com-
prised of six, nearly linearly arranged, hydrophobic
amino acids. As shown in Fig. 1d, the six amino acids in
CASKIN2 are K290, I341, F292, P338, R319, and Y336.
Notably, there is strong deviation at the first and fifth
positions, denoted by K290 and R319. Since the side
chains of the SH3 domain binding cleft are surface ex-
posed, K290 and R319 do not affect the protein fold,
and presumably, this is also the case for CASKIN1.
Table 1 Restraints and statistics for the ensemble of 15 structures
NOE restraints
Total 413
Intraresidue (|i – j| = 0) 204
Sequential (|i – j| = 1) 102
Medium range (1 < |i – j| < 5) 8
Long range (|i – j|≥ 5) 99
Additional restraints
Hydrogen bond distance restraints 32
Backbone angle torsion angle restraints 74
RMS deviationsa
Bonds 0.0123 ± 0.0003
Angles 1.2827 ± 0.0363
Improper angles 1.6905 ± 0.1112
Dihedral angles 0.2015 ± 0.1411
RMS violations
NOE restraints > 0.5 Å 0.0 ± 0.0
NOE restraints > 0.3 Å 2.3 ± 1.2
NOE restraints > 0.1 Å 25.5 ± 4.1
Dihedral angles > 5° 6.2 ± 0.6
Ramachandran analysis for ordered residuesb
Most favored regions 95.2 %
Additional allowed regions 4.8 %
Generously allowed regions 0.0 %
Disallowed regions 0.0 %
aAs reported by XPLOR-NIH 2.30 using the standard protein force field
bAs reported by PROCHECK for residues 284–292, 298–312, 320–324, 334–343
Table 2 Structurally similar proteins to the CASKIN2 SH3 domain
PDB Protein Source RMSD Aligned Identity
2DLP KIAA17833 NMR 1.1 Å 49 aa 29 %
1YN8 NBP2 X-ray 1.2 Å 49 aa 21 %
1UJ0 STAM2 + UBPY peptide X-ray 1.6 Å 57 aa 33 %
Kwan and Donaldson BMC Structural Biology  (2016) 16:14 Page 3 of 6
Given that the binding cleft deviates at two positions
from the typical set of amino acids observed in PxxP
type SH3 domains like Abl kinase [14] and RxxK type
SH3 domains like STAM2 [13], we hypothesized that
the CASKIN2 SH3 domain might bind an unconven-
tional peptide ligand. To answer this question, we
performed four successive rounds of panning a 6xHis
−-tagged CASKIN2 SH3 domain against a commercial
bacteriophage 12-mer peptide display library (PHD-12;
Novagen). A comparison of eight peptides from the last
round of panning revealed a Pxx[L/M/W] motif in many
of the candidates [presented in Additional file 1]. How-
ever, upon testing this motif with two chemically synthe-
sized peptides and one reversed peptide as a control, we
did not observe any binding in NMR based titrations
suggesting that the library may have identified a very
weak interaction. Since the phage display method failed
to identify a ligand for the CASKIN2 SH3 domain, it led
us to consider that the CASKIN2 SH3 domain might be
a non-functional remnant of the protein.
Figure 1e presents a comparison of high resolution
SH3 domain structures from the Protein Data Bank with
an emphasis on representatives having peptide binding
clefts that deviate from the usual complement of ali-
phatic and aromatic amino acids, and consequently, have
no ligands reported for them. The Abl SH3 domain
leads a set of sequences in Fig. 1e as a point of reference
and prototype for the typical array of aromatic and ali-
phatic amino acids that populate the six positions of the
binding cleft. Next to Abl in the presentation is the
RUN/TBC1 domain containing protein-3 SH3 domain
(PDB: 2YUO) that swaps an aromatic/aliphatic pair at
positions 5 and 6 of the cleft with a compensatory ali-
phatic/aromatic pair. A survey of the remaining repre-
sentatives in the figure demonstrate that it is possible
for each of the six binding cleft positions to tolerate a
hydrophilic or charged amino acid substitution. The
Crk-II SH3(2) domain represents the most extreme
case with substitutions at positions 1, 2, 5 and 6. Loss
of ligand binding in the Crk-II SH3(2) domain in the
context of the full adaptor protein is consistent with a
stabilizing function rather than a regulatory function in
this domain [15].
Substitution mutagenesis of the CASKIN2 peptide
binding cleft
A CASKIN2 SH3 domain double mutant (K290Y, R319W)
that we termed SH3-2x, was expressed to reintroduce a
full complement of aromatic amino acids in the peptide
binding cleft. Using circular dichroism (CD) spectroscopy,
the SH3-2x protein demonstrated a 20 °C increase in its
thermal denaturation midpoint (Table 3). This observation
suggests that aromatics in these two positions contribute
to the stability of the SH3 fold. Given the high degree of
structural similarity to the STAM2 SH3 domain in com-
plex with a UBPY peptide [16], we introduced four more
substitutions into the SH3-2x framework to produce a full
mimic of the STAM2 interaction in the CASKIN SH3 do-
main. Overall, this new mutant termed SH3-6x, contains
two substitutions to reintroduce aromatics (K290Y,
R319W), two minor substitutions that maintain hydropho-
bicity (Y336L, I341F) and two substitutions in the RT-loop
(H296E, A300E) that provide important complementary
ionic contacts to the UBPY peptide ligand in STAM2.
Since the SH3-2x mutant was a subset of the SH3-6x
mutant, the expressed protein had a similar thermal de-
naturation midpoint of 70 °C (Table 3). When tested
against a Class-III UBPY peptide containing an RxxKP
motif, high affinity binding (0.46 ± 0.11 μM) was ob-
served (Fig. 2) in the same order of magnitude as
another Class-III SH3 domain GADS with an SLP-76
peptide ligand [17]. As expected, the wild type
CASKIN2 SH3 domain had an over 100 fold less affin-
ity for the UBPY peptide. While ultralow affinity SH3
domains with biological relevance have been reported,
there is no evidence to suggest if CASKIN2 is among
this group [18, 19].
Conclusions
The NMR structure of the CASKIN2 SH3 domain dem-
onstrates a variant ligand binding cleft populated with
charged amino acids. Based on this unique feature, we
hypothesized that the CASKIN2 SH3 domain may bind
a ligand that does not belong to any of the canonical,
mainly proline-rich sequences that SH3 domains typic-
ally bind. Since a phage display failed to identify a ligand
for the CASKIN2 SH3 domain, we concluded that it
may indeed be non-functional. Increased thermal stabil-
ity and ligand binding could be engineered back into the
CASKIN2 SH3 domain sequence with relatively few
amino acid substitutions. This results presented in the
report emphasize the considerable versatility that SH3
domains, and signaling adaptor proteins, in general, have
at their disposal.
Methods
Cloning, expression and protein purification
The human CASKIN2 SH3 domain (aa. 284–348; Uni-
prot Q8WXE0) was amplified by PCR from a human
cDNA and inserted into the BamHI and XhoI restriction
Table 3 Thermal denaturation midpoints of CASKIN2 SH3
domain mutants
SH3 Mutation(s) Tm (°C)
WT none 50
2x K290Y, R319W 70
6x K290Y, H296E, A300E, R319W, Y336L, I341F 70
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sites of pGEX4T2 (GE Life Sciences) followed by trans-
formation into E. coli BL21:DE3 to produce a glutathione
S-transferase (GST) tagged fusion protein with interven-
ing thrombin protease cleavage site. Two CASKIN2 SH3
domain mutants, termed 2x and 6x, contained two aro-
matic substitutions to reconstitute a typical hydrophobic
binding cleft and six substitutions mimicking the canon-
ical binding cleft of the STAM2 SH3 domain. These
mutants were made using Quikchange method (Agilent).
All constructs were verified by sequencing at the York
University Core Facility. Isotopic labeling of wild type
GST-CASKIN2 SH3 domain and mutants for NMR spec-
troscopy was achieved by performing a 1.5 L fermentation
in a minimal medium containing 1 g of 15NH4Cl as the
sole nitrogen source and/or 3 g of 13C-glucose as the sole
carbon source. The cell pellet was suspended in T300 buf-
fer (20 mM Tris-HCl, 300 mM NaCl, 0.05 % NaN3) and
lysed by French press. Purification of the GST-CASKIN2
SH3 protein was achieved by glutathione affinity chroma-
tography (GE Biosciences). After an 8-h digestion with
activated human thrombin (Sigma-Aldrich), the SH3
domain was resolved from the GST carrier protein by gel
filtration chromatography (Sephacryl-100, HiLoad 16/60;
GE Life Sciences). The final buffer for all analyses was
phosphate buffered saline (PBS; 20 mM sodium phos-
phate, pH 7.8, 0.15 M NaCl, 0.05 % (w/v) sodium azide.
Circular dichroism
Far UV spectra (190–260 nm) of CASKIN SH3 proteins
at 20 μM in PBS were obtained on a Jasco J-810 spec-
tropolarimeter and processed with Spectra Analysis
1.54.04 software. A midpoint thermal denaturation
curve (Tm) was generated by monitoring the ellipticity
signal at 220 nm as the temperature was ramped from
20 to 90 °C at a rate of 1 °C/min.
Peptide binding
A solution of peptide YTPMVRENKPP at > 90 % purity
(Canpeptide; Montreal, QC) corresponding to the UBPY
ligand in the STAM2 SH3 domain structure (PDB:
1UJ0) was titrated into 1 μM wild type CASKIN2 SH3
domain, a 6x CASKIN-SH3 domain mutant, or a refer-
ence cell containing buffer only (10 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.05 % sodium azide). Upon exci-
tation at 280 nm, intrinsic fluorescence emission was
measured at 340 nm corresponding to one partially bur-
ied tryptophan in the CASKIN2 SH3 domain. Each
measurement was made three times and averaged.
NMR spectroscopy and structure determination
All experiments were performed on a uniformly 13C,15N
labeled sample of the CASKIN2 SH3 domain sample at
0.6 mM plus 10 % D2O. A conventional heteronuclear,
triple-resonance strategy was employed with all experi-
ments being acquired on an Agilent 600 MHz spectrometer
equipped with a 5 mm cryoprobe. Backbone directed ex-
periments : HNCACB and CBCAcoNH (15Nsw = 1450 Hz,
15Npts = 28;
13Csw, = 11309 Hz,
13Cpts = 40), HNCO and
HNcaCO (15Nsw = 1450 Hz,
15Npts = 28;
13Csw, = 2262 Hz,
13Cpts = 28). Side chain directed experiments: HccoNH
(15Nsw = 1450 Hz,
15Npts = 28;
1Hsw, = 6596 Hz,
1Hpts = 80),
hCcoNH (15Nsw = 1450 Hz,
15Npts = 28;
13Csw, = 11309 Hz,
13Cpts = 28), HCCH-TOCSY (
13Csw, = 11309 Hz,
13Cpts
= 28), aromatic HBcbcgCD and HBcbcgcdCE (13Csw, =
4524 Hz, 13Cpts = 32). Distance restrains were measures
from peak volumes from a 15N-edited NOESY (15Nsw =
1450 Hz, 15Npts = 28;
1Hsw, = 6596 Hz,
1Hpts = 80,
100 ms mixing time) and 13C-edited aliphatic (1Hsw, =
6596 Hz, 1Hpts = 80,
13Csw, = 2800 Hz,
13Cpts = 36,
100 ms mixing time) and aromatic 3D-NOESYs ali-
phatic (1Hsw, = 6596 Hz,
1Hpts = 80,
13Csw, = 2800 Hz,
13Cpts = 24, 100 ms mixing time). Datasets were proc-
essed with NMRpipe [20] and interpreted with
NMRView [21]. Distance restraints were obtained using
CYANA. Backbone torsion angles were predicted from
backbone chemical shift data with TALOS+ [22]. From
an initial set of 500 structures calculated with CYANA
2.0 [23], the top 25 structures were selected with no
NOE violations > 0.3 Å and no torsion angle violations
< 5°. This ensemble was then subjected to additional re-
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Fig. 2 An SH3-6x mutant (K290Y, H296E, A300E, R319W, Y336L, I341F)
mimics the binding cleft of the STAM2 SH3 domain in a CASKIN2 SH3
domain framework and consequently, high affinity towards a STAM2
ligand (YTPMVRENKPP) derived from the protein, UBPY. From direct
curve fitting against a binding equation describing a 1:1 protein to
peptide complex, the dissociation constants (Kd) of wild type
CASKIN2 SH3 domain and 6x mutant are 39 ± 6 μM and 220 ± 20
nM, respectively
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[25] and 15 final lowest energy structures were selected
for deposition to the Protein Data Bank.
Additional file
Additional file 1: Application of phage display to identify a potential
ligand for the CASKIN2 SH3 domain. (PDF 86 kb)
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